Arnicolide D is primarily studied for its anti-inflammatory and cytotoxic properties, making it a compound of interest in pharmaceutical research. It has shown potential in inhibiting the growth of certain cancer cell lines, suggesting possible application in oncology drug development. Additionally, its ability to modulate immune responses may support its use in treating inflammatory conditions. Due to its natural origin and bioactivity, Arnicolide D is also explored as a lead compound for synthesizing derivatives with enhanced therapeutic effects and reduced toxicity. Research remains largely in the preclinical stage, focusing on mechanism of action and efficacy in cellular and animal models.